venBio

Venture Capital Active San Francisco, United States Est. 2011
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
$111.0M
total disclosed, rounds participated
Stages
C Round, G Round, Pre-Seed, D Round, B Round, Seed, F Round, A Round, E Round

About

venBio is a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs. They are mindful of potential acquisition partners from the outset, and they ensure that their companies are best positioned to meet their requirements. This includes intellectual property (IP), chemistry, manufacturing (CMC), and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations.

Portfolio · 1

ImmPACT Bio
CAR-T Cell Therapies for Treating Cancer
Led ★ 1 round $111.0M committed Latest: 2022-01

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Funds · 2

  • 5 — $528M Aug 2024
  • 4 — $550M Jun 2021

Q&A

What is venBio's primary investment focus?
venBio is a life sciences investment firm that partners with industry leaders to build game-changing medicines and technologies, focusing on novel therapeutics for unmet medical needs.
What is venBio's most recent fund close?
venBio closed Fund 5 in August 2024, raising $528 million.
What was venBio's previous fund close?
venBio closed Fund 4 in June 2021, raising $550 million.
Can you name a notable exit for venBio?
In October 2024, venBio saw the acquisition of its portfolio company ImmPACT Bio by Lyell Immunopharma.
Which sector does venBio primarily invest in?
venBio primarily invests in the Health Tech & Life Sciences sector, as evidenced by its portfolio company ImmPACT Bio.
Who are the Managing Partners at venBio?
The Managing Partners at venBio are Robert Adelman, Richard Gaster, Aaron Royston, and Corey Goodman.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)